GGrantIndex
Sort

64,565 grants matching drug discovery

LITHIUM RESPONSIVE BIPOLAR DISORDER AND CNS MYO INOSITOL

$498,181
Wayne State University · R01 · FY2000 · MH

DEVELOPMENT OF HIV NON-VACCINE BIOMEDICAL PREVENTION PRODUCTS: PRODUCT ATTRIBUTES, POSITIONING, AND MESSAGING TO DRIVE ADOPTION AND USE OF NEW PERSONAL USE PRODUCTS

$498,099
Glen Swartz · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI

Molecular and biochemical basis of Lymphangioleiomyomatosis

$498,075
John Blenis · Harvard Medical School · R01 · FY2014 · HL

RUI: Characterizing Microvesicle-Mediated Rotavirus Transmission: Mechanisms and Evolutionary Impacts

$498,069
John J Dennehy · Cuny Queens College · · FY2025 · BIO

The role of ectodermal-neural cortex 1 in selective neuronal vulnerability in aging and Alzheimer's disease

$498,043
Hongjun Fu · Ohio State University · R56 · FY2020 · AG

mRNA Capping Enzymes

$498,040
Stewart H Shuman · Sloan-Kettering Inst Can Research · R01 · FY2008 · GM

Selective Inhibitors of T Cell Activation Target Exportin-1 at Cys528 to Suppress Pathological T Cell Activation

$498,038
Drew James Adams · Case Western Reserve University · R01 · FY2025 · AI

In-Vivo Spectroscopy/Imaging System PharmaScan 47/16

$498,000
University Of Colorado Denver · S10 · FY2005 · RR

Diacylglycerol kinase in airway smooth muscle functions

$497,986
Deepak A Deshpande · Thomas Jefferson University · R01 · FY2021 · HL

Regulation of manganese homeostasis and detoxification by SLC30A10

$497,965
Somshuvra Mukhopadhyay · University Of Texas At Austin · R01 · FY2020 · ES

Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma

$497,954
Courtney A Miller · University Of Florida · R33 · FY2023 · NS

Novel proteolytic mechanisms driving pathologic hepatic congestion in drug-induced hepatotoxicity

$497,939
James P Luyendyk · Michigan State University · R01 · FY2023 · DK

Restoration of Tumor Suppression Activity in Malignant Melanoma

$497,921
David Joseph Weber · University Of Maryland Baltimore · R01 · FY2009 · CA

AMBER force field consortium: a coherent biomolecular simulation platform

$497,886
Yong Duan · University Of California At Davis · R01 · FY2017 · GM

Structural Analysis of Macromolecular Assemblies

$497,847
Joachim Frank · Columbia University Health Sciences · R01 · FY2019 · GM

Molecular Target Focused Discovery of Anticancer Drugs

$497,835
George R Pettit · Arizona State University-Tempe Campus · R56 · FY2007 · CA

Proliferation and Differentiation of Bladder Epithelial Cells in Regeneration and Malignancy

$497,827
Philip A Beachy · Stanford University · R01 · FY2022 · CA

Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development

$497,710
Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2019 · AI

CAREER: Active Machine Learning for Automating Scientific Discovery

$497,693
Roman Garnett · Washington University · · FY2019 · CSE

Development of human 12/15-lipoxygenase therapeutics for stroke

$497,644
Klaus Van Leyen · Massachusetts General Hospital · UG3 · FY2018 · NS

Pulmonary vagal sensory neurons in chronic lung disease

$497,628
Gary Charles Mouradian · Medical College Of Wisconsin · R01 · FY2025 · HL

Osteoporosis Screen for Praja1 E3 Ligase Inhibitors

$497,620
Michael R Mattern · Progenra, Inc. · R44 · FY2007 · AG

Inhibition or evasion of P-glycoprotein-mediated drug transport

$497,527
Qinghai Zhang · Scripps Research Institute, The · R01 · FY2024 · GM

Inhibition or evasion of P-glycoprotein-mediated drug transport

$497,527
Qinghai Zhang · Scripps Research Institute, The · R01 · FY2025 · GM

Tolerance and Physical Dependence after Chronic Benzodiazepine Treatment

$497,519
James K Rowlett · University Of Mississippi Med Ctr · R01 · FY2017 · DA